| A SARS-CoV-2 protein interaction map reveals targets for drug repurposing DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier, KM White, ... Nature 583 (7816), 459-468, 2020 | 4330 | 2020 |
| A serological assay to detect SARS-CoV-2 seroconversion in humans F Amanat, D Stadlbauer, S Strohmeier, THO Nguyen, V Chromikova, ... Nature medicine 26 (7), 1033-1036, 2020 | 1998 | 2020 |
| The global phosphorylation landscape of SARS-CoV-2 infection M Bouhaddou, D Memon, B Meyer, KM White, VV Rezelj, MC Marrero, ... Cell 182 (3), 685-712. e19, 2020 | 859 | 2020 |
| Zika virus targets human STAT2 to inhibit type I interferon signaling A Grant, SS Ponia, S Tripathi, V Balasubramaniam, L Miorin, ... Cell host & microbe 19 (6), 882-890, 2016 | 824 | 2016 |
| Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, L Pache, ... Nature 586 (7827), 113-119, 2020 | 726 | 2020 |
| Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen D Maione, I Margarit, CD Rinaudo, V Masignani, M Mora, M Scarselli, ... Science 309 (5731), 148-150, 2005 | 667 | 2005 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 608 | 2020 |
| SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ... Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020 | 470 | 2020 |
| MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells X Yin, L Riva, Y Pu, L Martin-Sancho, J Kanamune, Y Yamamoto, K Sakai, ... Cell reports 34 (2), 2021 | 341 | 2021 |
| Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A KM White, R Rosales, S Yildiz, T Kehrer, L Miorin, E Moreno, S Jangra, ... Science 371 (6532), 926-931, 2021 | 292 | 2021 |
| Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience C Bryce, Z Grimes, E Pujadas, S Ahuja, MB Beasley, R Albrecht, ... Modern Pathology 34 (8), 1456-1467, 2021 | 226 | 2021 |
| An in vitro microneutralization assay for SARS‐CoV‐2 serology and drug screening F Amanat, KM White, L Miorin, S Strohmeier, M McMahon, P Meade, ... Current protocols in microbiology 58 (1), e108, 2020 | 173 | 2020 |
| Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression K Zhang, L Miorin, T Makio, I Dehghan, S Gao, Y Xie, H Zhong, M Esparza, ... Science Advances 7 (6), eabe7386, 2021 | 171 | 2021 |
| Functional landscape of SARS-CoV-2 cellular restriction L Martin-Sancho, MK Lewinski, L Pache, CA Stoneham, X Yin, ME Becker, ... Molecular cell 81 (12), 2656-2668. e8, 2021 | 170 | 2021 |
| The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon M Laurent-Rolle, J Morrison, R Rajsbaum, JML Macleod, G Pisanelli, ... Cell host & microbe 16 (3), 314-327, 2014 | 167 | 2014 |
| Three-dimensional architecture of tick-borne encephalitis virus replication sites and trafficking of the replicated RNA L Miorin, I Romero-Brey, P Maiuri, S Hoppe, J Krijnse-Locker, ... Journal of virology 87 (11), 6469-6481, 2013 | 154 | 2013 |
| Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response R Rajsbaum, GA Versteeg, S Schmid, AM Maestre, A Belicha-Villanueva, ... Immunity 40 (6), 880-895, 2014 | 151 | 2014 |
| COVID-19: famotidine, histamine, mast cells, and mechanisms RW Malone, P Tisdall, P Fremont-Smith, Y Liu, XP Huang, KM White, ... Frontiers in Pharmacology 12, 633680, 2021 | 149 | 2021 |
| The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera R Rathnasinghe, S Jangra, A Cupic, C Martínez-Romero, LCF Mulder, ... MedRxiv, 2021 | 113 | 2021 |
| Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice JA Silvas, DM Vasquez, JG Park, K Chiem, A Allué-Guardia, ... Journal of Virology 95 (17), 10.1128/jvi. 00402-21, 2021 | 104 | 2021 |
Vinod BalasubramaniamGroup Leader and Associate Professor at Jeffrey Cheah School of Medicine and Health Sciences, MonashGeverifieerd e-mailadres voor monash.edu
